CBD

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) traded up as much as 82.6 percent Thursday after reporting positive top-line results for its uncontrolled phase 2 study of ZYN002 in children with Fragile X syndrome. The synthetic cannabinoid transdermal gel “successfully met its primary endpoint...

Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Risk Mitigation Through Diversification The company announced Tuesday positive top...

With medical and recreational marijuana quickly becoming a booming business in the U.S., farmers with newly issued licenses to grow hemp are finding it difficult to carve out their own place in the market. Hemp farmers in several states are beginning their second growing season this year, though...

(Note: This is the second of a two-part interview with Terra Tech Corp. CEO Derek Peterson. Click here for part one) Terra Tech Corp (OTC: TRTC), and its subsidiary, GrowOp Technology Ltd, is working on the development of a CBD supplement with the medical research firm Intergetics (OTC: NRTI...